BriaCell Therapeutics Corp.
BCTXW · NASDAQ
10/31/2025 | 7/31/2025 | 4/30/2025 | 1/31/2025 | |
|---|---|---|---|---|
| Market Cap | $113 | $73 | $0 | $3,023 |
| - Cash | $2,714 | $10,494 | $12,460 | $5,014 |
| + Debt | $0 | $0 | $0 | $0 |
| Enterprise Value | -$2,601 | -$10,421 | -$12,460 | -$1,990 |
| Revenue | $0 | $0 | $0 | $0 |
| % Growth | – | – | – | – |
| Gross Profit | -$26 | -$26 | -$27 | $0 |
| % Margin | – | – | – | – |
| EBITDA | -$8,169 | $18,536 | -$6,161 | -$7,143 |
| % Margin | – | – | – | – |
| Net Income | -$8,116 | -$8,025 | -$6,127 | -$6,291 |
| % Margin | – | – | – | – |
| EPS Diluted | -4.31 | -4.26 | -1,640.18 | -0.35 |
| % Growth | -1.2% | 99.7% | -468,522.9% | – |
| Operating Cash Flow | -$7,628 | -$8,132 | -$7,163 | -$5,920 |
| Capital Expenditures | $0 | $0 | $0 | $0 |
| Free Cash Flow | -$7,628 | -$8,132 | -$7,163 | -$5,920 |